| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0 | 0.984 | Leukotriene antagonist | 0.946 0.001 DBMET01243 0.931 0.001 DBMET01244 0.931 0.001 DBMET01245 0.984 0 DBMET01246 0.984 0 DBMET01247 0.983 0 DBMET01248 0.983 0 DBMET01249 0.931 0.001 DBMET01706 0.984 0 DBMET01707 0.984 0 DBMET01708 0.983 0 DBMET01709 | DBMET01708 | |
| 0.948 | 0.001 | 0.948 | Leukotriene D4 antagonist | 0.874 0.001 DBMET01243 0.859 0.001 DBMET01244 0.859 0.001 DBMET01245 0.946 0.001 DBMET01246 0.946 0.001 DBMET01247 0.913 0.001 DBMET01248 0.913 0.001 DBMET01249 0.859 0.001 DBMET01706 0.946 0.001 DBMET01707 0.946 0.001 DBMET01708 0.913 0.001 DBMET01709 | ||
| 0.924 | 0 | 0.924 | Leukotriene C antagonist | 0.386 0.001 DBMET01243 0.577 0.001 DBMET01244 0.577 0.001 DBMET01245 0.753 0 DBMET01246 0.753 0 DBMET01247 0.849 0 DBMET01248 0.849 0 DBMET01249 0.577 0.001 DBMET01706 0.753 0 DBMET01707 0.753 0 DBMET01708 0.849 0 DBMET01709 | ||
| 0.923 | 0 | 0.923 | Leukotriene C4 antagonist | 0.369 0.001 DBMET01243 0.57 0.001 DBMET01244 0.57 0.001 DBMET01245 0.752 0 DBMET01246 0.752 0 DBMET01247 0.85 0 DBMET01248 0.85 0 DBMET01249 0.57 0.001 DBMET01706 0.752 0 DBMET01707 0.752 0 DBMET01708 0.85 0 DBMET01709 | ||
| 0.856 | 0.005 | 0.856 | Toll-Like receptor 7 agonist | 0.731 0.007 DBMET01243 0.682 0.01 DBMET01244 0.682 0.01 DBMET01245 0.781 0.005 DBMET01246 0.781 0.005 DBMET01247 0.836 0.005 DBMET01248 0.836 0.005 DBMET01249 0.682 0.01 DBMET01706 0.781 0.005 DBMET01707 0.781 0.005 DBMET01708 0.836 0.005 DBMET01709 | ||
| 0.853 | 0.005 | 0.853 | Toll-Like receptor agonist | 0.732 0.007 DBMET01243 0.676 0.01 DBMET01244 0.676 0.01 DBMET01245 0.775 0.005 DBMET01246 0.775 0.005 DBMET01247 0.833 0.005 DBMET01248 0.833 0.005 DBMET01249 0.676 0.01 DBMET01706 0.775 0.005 DBMET01707 0.775 0.005 DBMET01708 0.833 0.005 DBMET01709 | ||
| 0.785 | 0.017 | 0.909 | Antiinflammatory | 0.845 0.01 DBMET01243 0.619 0.049 DBMET01244 0.619 0.049 DBMET01245 0.909 0.005 DBMET01246 0.909 0.005 DBMET01247 0.837 0.011 DBMET01248 0.837 0.011 DBMET01249 0.619 0.049 DBMET01706 0.909 0.005 DBMET01707 0.909 0.005 DBMET01708 0.837 0.011 DBMET01709 | DBMET01708 | |
| 0.639 | 0.002 | 0.639 | Leukotriene synthesis inhibitor | 0.466 0.003 DBMET01243 0.464 0.003 DBMET01244 0.464 0.003 DBMET01245 0.505 0.003 DBMET01246 0.505 0.003 DBMET01247 0.566 0.002 DBMET01248 0.566 0.002 DBMET01249 0.464 0.003 DBMET01706 0.505 0.003 DBMET01707 0.505 0.003 DBMET01708 0.566 0.002 DBMET01709 | ||
| 0.375 | 0.054 | 0.375 | Streptokinase A inhibitor | 0.175 0.151 DBMET01244 0.175 0.151 DBMET01245 0.257 0.099 DBMET01246 0.257 0.099 DBMET01247 0.294 0.082 DBMET01248 0.294 0.082 DBMET01249 0.175 0.151 DBMET01706 0.257 0.099 DBMET01707 0.257 0.099 DBMET01708 0.294 0.082 DBMET01709 | ||
| 0.245 | 0.024 | 0.245 | Phospholipase A2 inhibitor | 0.188 0.05 DBMET01243 0.147 0.078 DBMET01244 0.147 0.078 DBMET01245 0.18 0.054 DBMET01246 0.18 0.054 DBMET01247 0.235 0.027 DBMET01248 0.235 0.027 DBMET01249 0.147 0.078 DBMET01706 0.18 0.054 DBMET01707 0.18 0.054 DBMET01708 0.235 0.027 DBMET01709 | ||
| 0.284 | 0.079 | 0.284 | Lipoxygenase inhibitor | 0.215 0.126 DBMET01244 0.215 0.126 DBMET01245 0.213 0.127 DBMET01246 0.213 0.127 DBMET01247 0.264 0.091 DBMET01248 0.264 0.091 DBMET01249 0.215 0.126 DBMET01706 0.213 0.127 DBMET01707 0.213 0.127 DBMET01708 0.264 0.091 DBMET01709 | ||
| 0.216 | 0.06 | 0.216 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.172 0.103 DBMET01246 0.172 0.103 DBMET01247 0.184 0.09 DBMET01248 0.184 0.09 DBMET01249 0.172 0.103 DBMET01707 0.172 0.103 DBMET01708 0.184 0.09 DBMET01709 | ||
| 0.296 | 0.167 | 0.507 | Cyclophilin D inhibitor | 0.507 0.048 DBMET01243 0.263 0.198 DBMET01246 0.263 0.198 DBMET01247 0.505 0.049 DBMET01248 0.505 0.049 DBMET01249 0.263 0.198 DBMET01707 0.263 0.198 DBMET01708 0.505 0.049 DBMET01709 | DBMET01243 | |
| 0.118 | 0.005 | 0.118 | Thromboxane synthase inhibitor | 0.072 0.016 DBMET01244 0.072 0.016 DBMET01245 0.073 0.015 DBMET01246 0.073 0.015 DBMET01247 0.088 0.009 DBMET01248 0.088 0.009 DBMET01249 0.072 0.016 DBMET01706 0.073 0.015 DBMET01707 0.073 0.015 DBMET01708 0.088 0.009 DBMET01709 | ||
| 0.112 | 0.014 | 0.112 | Elastase 1 inhibitor | 0.067 0.05 DBMET01243 0.112 0.014 DBMET01244 0.112 0.014 DBMET01245 0.098 0.021 DBMET01246 0.098 0.021 DBMET01247 0.104 0.018 DBMET01248 0.104 0.018 DBMET01249 0.112 0.014 DBMET01706 0.098 0.021 DBMET01707 0.098 0.021 DBMET01708 0.104 0.018 DBMET01709 | ||
| 0.095 | 0.008 | 0.095 | Heme oxygenase stimulant | 0.08 0.015 DBMET01243 0.094 0.009 DBMET01244 0.094 0.009 DBMET01245 0.091 0.01 DBMET01246 0.091 0.01 DBMET01247 0.09 0.01 DBMET01248 0.09 0.01 DBMET01249 0.094 0.009 DBMET01706 0.091 0.01 DBMET01707 0.091 0.01 DBMET01708 0.09 0.01 DBMET01709 | ||
| 0.145 | 0.059 | 0.145 | Farnesoid X receptor antagonist | 0.143 0.061 DBMET01246 0.143 0.061 DBMET01247 0.142 0.063 DBMET01248 0.142 0.063 DBMET01249 0.143 0.061 DBMET01707 0.143 0.061 DBMET01708 0.142 0.063 DBMET01709 | ||
| 0.167 | 0.092 | 0.311 | Hepatoprotectant | 0.311 0.027 DBMET01243 0.159 0.1 DBMET01246 0.159 0.1 DBMET01247 0.16 0.1 DBMET01248 0.16 0.1 DBMET01249 0.159 0.1 DBMET01707 0.159 0.1 DBMET01708 0.16 0.1 DBMET01709 | DBMET01243 | |
| 0.123 | 0.051 | 0.123 | Nav1.5 sodium channel blocker | |||
| 0.086 | 0.017 | 0.091 | Thromboxane antagonist | 0.091 0.014 DBMET01244 0.091 0.014 DBMET01245 0.049 0.043 DBMET01246 0.049 0.043 DBMET01247 0.057 0.035 DBMET01248 0.057 0.035 DBMET01249 0.091 0.014 DBMET01706 0.049 0.043 DBMET01707 0.049 0.043 DBMET01708 0.057 0.035 DBMET01709 | DBMET01706 | |
| 0.073 | 0.005 | 0.074 | p53 inhibitor | 0.074 0.005 DBMET01244 0.074 0.005 DBMET01245 0.07 0.005 DBMET01246 0.07 0.005 DBMET01247 0.07 0.005 DBMET01248 0.07 0.005 DBMET01249 0.074 0.005 DBMET01706 0.07 0.005 DBMET01707 0.07 0.005 DBMET01708 0.07 0.005 DBMET01709 | DBMET01706 | |
| 0.102 | 0.047 | 0.115 | ABCA1 expression enhancer | 0.108 0.04 DBMET01244 0.108 0.04 DBMET01245 0.115 0.034 DBMET01246 0.115 0.034 DBMET01247 0.086 0.073 DBMET01248 0.086 0.073 DBMET01249 0.108 0.04 DBMET01706 0.115 0.034 DBMET01707 0.115 0.034 DBMET01708 0.086 0.073 DBMET01709 | DBMET01708 | |
| 0.103 | 0.061 | 0.103 | 5-Lipoxygenase inhibitor | 0.094 0.068 DBMET01244 0.094 0.068 DBMET01245 0.084 0.077 DBMET01246 0.084 0.077 DBMET01247 0.094 0.068 DBMET01706 0.084 0.077 DBMET01707 0.084 0.077 DBMET01708 | ||
| 0.102 | 0.061 | 0.16 | Bronchodilator | 0.16 0.028 DBMET01246 0.16 0.028 DBMET01247 0.16 0.028 DBMET01707 0.16 0.028 DBMET01708 | DBMET01708 | |
| 0.158 | 0.128 | 0.208 | Hypolipemic | 0.179 0.111 DBMET01243 0.161 0.126 DBMET01244 0.161 0.126 DBMET01245 0.208 0.088 DBMET01246 0.208 0.088 DBMET01247 0.161 0.126 DBMET01706 0.208 0.088 DBMET01707 0.208 0.088 DBMET01708 | DBMET01708 | |
| 0.094 | 0.065 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.052 DBMET01246 0.103 0.052 DBMET01247 0.103 0.052 DBMET01707 0.103 0.052 DBMET01708 | DBMET01708 | |
| 0.088 | 0.065 | 0.095 | Thioredoxin inhibitor | 0.095 0.054 DBMET01243 0.085 0.071 DBMET01244 0.085 0.071 DBMET01245 0.085 0.071 DBMET01706 | DBMET01243 | |
| 0.055 | 0.035 | 0.065 | Leukotriene B4 antagonist | 0.059 0.029 DBMET01244 0.059 0.029 DBMET01245 0.065 0.023 DBMET01246 0.065 0.023 DBMET01247 0.053 0.038 DBMET01248 0.053 0.038 DBMET01249 0.059 0.029 DBMET01706 0.065 0.023 DBMET01707 0.065 0.023 DBMET01708 0.053 0.038 DBMET01709 | DBMET01708 | |
| 0.035 | 0.017 | 0.035 | AMPA 2 receptor antagonist | 0.032 0.019 DBMET01244 0.032 0.019 DBMET01245 0.027 0.024 DBMET01248 0.027 0.024 DBMET01249 0.032 0.019 DBMET01706 0.027 0.024 DBMET01709 | ||
| 0.063 | 0.047 | 0.063 | Beta 3 adrenoreceptor antagonist | |||
| 0.031 | 0.017 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 DBMET01244 0.031 0.017 DBMET01245 0.028 0.023 DBMET01246 0.028 0.023 DBMET01247 0.031 0.017 DBMET01706 0.028 0.023 DBMET01707 0.028 0.023 DBMET01708 | ||
| 0.065 | 0.053 | 0.065 | Peroxisome proliferator-activated receptor gamma agonist | 0.064 0.055 DBMET01244 0.064 0.055 DBMET01245 0.064 0.055 DBMET01706 | ||
| 0.032 | 0.02 | 0.032 | Liver X receptor antagonist | 0.032 0.02 DBMET01244 0.032 0.02 DBMET01245 0.032 0.02 DBMET01706 | ||
| 0.041 | 0.033 | 0.041 | Liver X receptor agonist | 0.041 0.034 DBMET01244 0.041 0.034 DBMET01245 0.041 0.034 DBMET01706 | ||
| 0.052 | 0.049 | 0.066 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET01244 0.056 0.045 DBMET01245 0.066 0.036 DBMET01246 0.066 0.036 DBMET01247 0.056 0.045 DBMET01706 0.066 0.036 DBMET01707 0.066 0.036 DBMET01708 | DBMET01708 | |
| 0.043 | 0.047 | 0.047 | Prostaglandin antagonist | 0.047 0.042 DBMET01244 0.047 0.042 DBMET01245 0.047 0.042 DBMET01706 | DBMET01706 | |
| 0.157 | 0.167 | 0.336 | Hypoglycemic | 0.336 0.041 DBMET01243 | DBMET01243 | |
| 0.029 | 0.062 | 0.055 | Thromboxane A2 antagonist | 0.055 0.032 DBMET01244 0.055 0.032 DBMET01245 0.055 0.032 DBMET01706 | DBMET01706 | |
| 0.108 | 0.16 | 0.251 | Nitric oxide antagonist | 0.251 0.051 DBMET01243 0.16 0.087 DBMET01248 0.16 0.087 DBMET01249 0.16 0.087 DBMET01709 | DBMET01243 | |
| 0.119 | 0.188 | 0.179 | Platelet antagonist | 0.179 0.118 DBMET01243 0.156 0.138 DBMET01244 0.156 0.138 DBMET01245 0.156 0.138 DBMET01706 | DBMET01243 | |
| 0.111 | 0.189 | 0.21 | Non-steroidal antiinflammatory agent | 0.21 0.064 DBMET01243 | DBMET01243 | |
| 0.113 | 0.202 | 0.64 | Free radical scavenger | 0.344 0.04 DBMET01243 0.64 0.007 DBMET01244 0.64 0.007 DBMET01245 0.64 0.007 DBMET01706 | DBMET01706 | |
| 0.057 | 0.176 | 0.105 | DNA polymerase I inhibitor | 0.105 0.081 DBMET01243 | DBMET01243 | |
| 0.099 | 0.237 | 0.314 | Tumour necrosis factor alpha release inhibitor | 0.314 0.048 DBMET01243 | DBMET01243 | |
| 0.103 | 0.247 | 0.505 | Antioxidant | 0.359 0.044 DBMET01243 0.505 0.019 DBMET01244 0.505 0.019 DBMET01245 0.505 0.019 DBMET01706 | DBMET01706 | |
| 0.025 | 0.201 | 0.048 | Factor IXa inhibitor | 0.048 0.04 DBMET01243 | DBMET01243 | |
| 0.024 | 0.211 | 0.047 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 DBMET01243 | DBMET01243 | |
| 0.031 | 0.226 | 0.121 | Topoisomerase I inhibitor | 0.121 0.055 DBMET01243 | DBMET01243 | |
| 0.123 | 0.348 | 0.294 | Apoptosis antagonist | 0.294 0.089 DBMET01243 | DBMET01243 | |
| 0.096 | 0.345 | 0.21 | Cholesterol antagonist | 0.21 0.156 DBMET01243 | DBMET01243 | |
| 0.012 | 0.298 | 0.166 | Selectin antagonist | 0.166 0.015 DBMET01243 | DBMET01243 | |
| 0.043 | 0.332 | 0.355 | Angiogenesis stimulant | 0.355 0.031 DBMET01243 | DBMET01243 | |
| 0.075 | 0.373 | 0.423 | Transcription factor NF kappa B inhibitor | 0.423 0.059 DBMET01243 | DBMET01243 | |
| 0.04 | 0.338 | 0.131 | Toll-Like receptor 4 antagonist | 0.131 0.034 DBMET01243 | DBMET01243 | |
| 0.041 | 0.35 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.063 DBMET01243 | DBMET01243 | |
| 0.112 | 0.425 | 0.301 | Interleukin 2 agonist | 0.301 0.073 DBMET01243 | DBMET01243 | |
| 0.026 | 0.378 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.044 DBMET01243 | DBMET01243 | |
| 0.037 | 0.394 | 0.127 | Cell wall synthesis inhibitor | 0.127 0.09 DBMET01243 | DBMET01243 | |
| 0.051 | 0.426 | 0.123 | NOS3 expression enhancer | 0.123 0.109 DBMET01243 | DBMET01243 | |
| 0.024 | 0.434 | 0.116 | Thrombolytic | 0.116 0.115 DBMET01243 | DBMET01243 | |
| 0.055 | 0.466 | 0.321 | Immunosuppressant | 0.321 0.102 DBMET01243 | DBMET01243 | |
| 0.06 | 0.474 | 0.214 | Antithrombotic | 0.214 0.161 DBMET01243 | DBMET01243 | |
| 0.024 | 0.442 | 0.133 | Lipid peroxidase inhibitor | 0.133 0.081 DBMET01243 | DBMET01243 | |
| 0.037 | 0.476 | 0.155 | Platelet adhesion inhibitor | 0.155 0.101 DBMET01243 | DBMET01243 | |
| 0.07 | 0.563 | 0.387 | Apoptosis agonist | 0.387 0.12 DBMET01243 | DBMET01243 | |
| 0.076 | 0.645 | 0.236 | Peptidyltransferase inhibitor | 0.236 0.061 DBMET01243 | DBMET01243 | |
| 0.024 | 0.687 | 0.456 | Antibacterial | 0.456 0.055 DBMET01243 | DBMET01243 | |
| 0.008 | 0.672 | 0.05 | Protein 50S ribosomal subunit inhibitor | 0.05 0.04 DBMET01243 | DBMET01243 | |
| 0.008 | 0.786 | 0.039 | Antibiotic Aminoglycoside-like | 0.039 0.022 DBMET01243 | DBMET01243 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |